Sort by

Send to

Choose Destination

Links from PubMed

Items: 2


Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH.

Clin Cancer Res. 2000 Feb;6(2):390-6.


Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Chen TC, Fonseca CO, Schönthal AH.

Am J Cancer Res. 2015 Apr 15;5(5):1580-93. eCollection 2015. Review.

Supplemental Content

Support Center